Congenital Amegakaryocytic Thrombocytopenia (CAMT)
Showing 1 - 25 of 2,419
Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Recruiting
- Primary Immunodeficiency (PID)
- +4 more
- data collection
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Feb 9, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection
Active, not recruiting
- Bone Marrow Failure Syndrome
- +15 more
- CD34 Stem Cell Selection Therapy
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- QL0911
- Placebo
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Sep 21, 2022
Outcome of Thrombocytopenia in ICU Patients
Not yet recruiting
- Thrombocytopenia
- (no location specified)
Jul 15, 2023
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Study of Severe Fever With Thrombocytopenia Syndrome
Recruiting
- Severe Fever With Thrombocytopenia Syndrome
-
Guangshui, Hubei, China
- +7 more
Aug 21, 2023
Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)
Completed
- Thrombocytopenia Purpura
- Chronic HBV Infection
-
Tianjin, Tianjin, ChinaEthics Committee of Blood disease hospital, Chinese Academy of M
Jan 24, 2023
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Ketogenic Diet Trial (Strict ketogenic diet group, Cyclic ketogenic diet group, Autonomous ketogenesis group)
Not yet recruiting
- Ketogenic Diet
- Strict ketogenic diet group
- +2 more
- (no location specified)
Oct 26, 2023
Pattern of Congenital Hypothyroidism in Newborns.
Not yet recruiting
- Pattern of CH
- (no location specified)
Sep 26, 2023
Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +2 more
- (no location specified)
Jun 26, 2023
Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)
Not yet recruiting
- Connective Tissue Diseases
- Thrombocytopenia
- Telitacicept
- Placebo
-
Hefei, Anhui, China
- +21 more
Aug 18, 2023
Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)
Not yet recruiting
- Chronic Primary Immune Thrombocytopenia (ITP)
- Qrelabrutinib
- Placebo
-
Bengbu, Anhui, China
- +13 more
Aug 15, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Clinical Performance Evaluation of T-TAS®01 HD Chip
Recruiting
- Thrombocytopenia
- T-TAS 01 HD Assay
-
San Francisco, California
- +5 more
Oct 11, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Eltrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023